Hospital Clinic, IDIBAPS, Universitat de Barcelona and CIBER Enfermedades Respiratorias, FISIB, Mallorca, Spain.
Eur Respir J. 2013 Sep;42(3):636-46. doi: 10.1183/09031936.00195212. Epub 2013 Jun 13.
The 2011 Global Initiative for Chronic Obstructive Lung Disease (GOLD) classifies patients with chronic obstructive pulmonary disease (COPD) into four groups (A to D). We explored the characteristics, stability and relationship to outcomes of these groups within the ECLIPSE study (Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points) (n = 2101). Main results showed that: 1) these groups differed in several clinical, functional, imaging and biological characteristics in addition to those used for their own definition; 2) A and D groups were relatively stable over time, whereas groups B and C showed more temporal variability; 3) the risk of exacerbation over 3 years increased progressively from A to D, whereas that of hospitalisation and mortality were lowest in A, highest in D and intermediate and similar in B and C, despite the former having milder airflow limitation. The prevalence of comorbidities and persistent systemic inflammation were highest in group B. The different longitudinal behaviour of group A versus B and C versus D (each pair with similar forced expiratory volume in1 s (FEV1) values supports the 2011 GOLD proposal of assessing COPD patients by more than FEV1 only. However the assumption that symptoms do not equate to risk appears to be naïve, as groups B and C carry equally poor clinical outcomes, though for different reasons.
2011 年全球慢性阻塞性肺疾病倡议(GOLD)将慢性阻塞性肺疾病(COPD)患者分为四组(A 至 D 组)。我们在 ECLIPSE 研究(COPD 的纵向评估以确定预测替代终点)(n = 2101)中探讨了这些组的特征、稳定性及其与结局的关系。主要结果显示:1)这些组在临床、功能、影像学和生物学特征方面存在差异,除了用于定义这些组的特征外;2)A 组和 D 组在时间上相对稳定,而 B 组和 C 组则表现出更多的时间变异性;3)3 年内加重的风险从 A 组到 D 组逐渐增加,而 A 组的住院和死亡率最低,D 组最高,B 组和 C 组居中且相似,尽管前者的气流受限较轻。B 组的合并症和持续全身炎症发生率最高。A 组与 B 组和 C 组与 D 组(每组的用力呼气量 1 秒率(FEV1)值相似)的纵向行为不同,这支持 2011 年 GOLD 提出的不仅通过 FEV1 评估 COPD 患者的建议。然而,症状不等同于风险的假设似乎是幼稚的,因为 B 组和 C 组同样存在不良的临床结局,尽管原因不同。